Theranos and its founder settle U.S. fraud charges - SEC

Theranos Inc and its Chief Executive Elizabeth Holmes have agreed to settle fraud charges in a deal that strips her of control over the embattled blood-testing company, among other penalties, U.S. regulators said on Wednesday.

As part of the settlement, the Securities and Exchange Commission said Holmes must also return millions of shares to the privately-held company and cannot serve as an officer or director of a public company for 10 years.

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)